REGN5678

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for REGN5678, covering 2026-01-15 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC [Phase 1]